Xenon Pharmaceuticals (NASDAQ: XENE) files mixed shelf registration statement of:

Common Shares
Preferred Shares
Warrants
Units

Corporate News Equity Offerings FDA Hot Corp. News

Xenon Pharmaceuticals (XENE) Prices 8.47M Share Offering at $29.50/shOctober 6, 2021 5:44 AM Form S-3ASR Xenon Pharmaceuticals October 4, 2021 4:02 PM Xenon Pharmaceuticals (XENE) PT Raised to $50 at JefferiesOctober 4, 2021 11:23 AM Xenon Pharmaceuticals (XENE) PT Raised to $45 at Wedbush, Following Clinical Business UpdateOctober 4, 2021 11:04 AM Xenon Pharmaceuticals (XENE) PT Raised to $45 at Guggenheim, Following Clinical Business UpdateOctober 4, 2021 10:51 AM Xenon Pharmaceuticals (XENE) PT Raised to $44 at StifelOctober 4, 2021 10:39 AM Pre-Open Stock Movers 10/04: (XENE) (ADVM) (OSUR) Higher; (MRNA) (NEO) (IIVI) Lower (more...)October 4, 2021 9:25 AM Xenon's (XENE) X-Tole Data as Good as it Gets with Best-in-Category Efficacy - AnalystOctober 4, 2021 8:56 AM Xenon Pharmaceuticals (XENE) Phase 2b 'X-TOLE' Clinical Trial of XEN1101 for the Treatment of Focal Epilepsy Met its Primary Efficacy EndpointOctober 4, 2021 7:01 AM